Full Text View
Tabular View
No Study Results Posted
Related Studies
Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA)
This study is currently recruiting participants.
Verified July 2012 by University of Rochester
Study NCT01098201   Information provided by University of Rochester

First Received on March 30, 2010.   Last Updated on July 27, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Rheumatoid Arthritis
Additional conditions recognized in this trial
Arthritis
Arthritis, Rheumatoid
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
Certolizumab
Additional drug interventions recognized in this trial
Immunoglobulin Fab Fragments
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of Rochester


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services